Qiagen NV Profit Margin

Qiagen NV (QGEN) currently reports a profit margin of 19.49% as of June 2026. That compares with 18.3% in the prior-year period — up 6.5% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Qiagen NV's profit margin history and peer comparisons.

Qiagen NV's profit margin increased from 18.3% to 19.49% — a 6.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Qiagen NV's profit margin of 19.49% is higher than the Healthcare sector average of 13.89%. That is roughly 40.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Qiagen NV's current 19.49% should be judged against Healthcare norms (sector average: 13.89%) and against QGEN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 19.49%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Qiagen NV, and consider following QGEN for alerts when major investors trade the stock.